284 results
Page 13 of 15
PRE 14A
4rf28trg
14 Mar 13
Preliminary proxy
12:00am
8-K
EX-99.1
bn0v s6da
5 Feb 13
NewLink Genetics Corporation Announces Exercise of Underwriters' Option and Closing of Public Offering of Common Stock
12:00am
8-K
EX-99.2
k62rub
31 Jan 13
NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
12:00am
424B5
wtvs5b4fpffjt4cn
31 Jan 13
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
31yigcf3mhkmyyf 10qd
31 Jan 13
NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
12:00am
8-K
EX-99.1
nrj18t615onm 09wc
31 Jan 13
NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
12:00am
424B5
npisd4bfblhsarkxt5p
29 Jan 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
ri4zr9itc
4 Jan 13
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
12:00am
8-K
EX-99.1
7v38gj pwc7egh6w8m
13 Dec 12
Clinical Data from NewLink Genetics' HyperAcute Prostate Cancer Immunotherapy Published in Journal of Immunotherapy
12:00am
8-K
EX-99.1
15dviebhq2
31 Oct 12
NewLink Genetics Corporation Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
0f5472nscgm 8v
10 Oct 12
Other Events
12:00am
8-K
EX-99.1
qyst33qq6q
3 Oct 12
NewLink Genetics Launches Adaptive Design Phase 2B/3 Clinical Trial of tergenpumatucel-L Immunotherapy in Patients with Non-Small Cell Lung Cancer
12:00am
DEF 14A
5hzmyjz1uwt4
21 Sep 12
Definitive proxy
12:00am
8-K
EX-99.1
futzto a9dkxj65
21 Sep 12
Other Events
12:00am
8-K
EX-99.1
mgl20v6kyx132rmu
19 Jun 12
Other Events
12:00am
8-K
kw96d
5 Jun 12
Other Events
12:00am